446 related articles for article (PubMed ID: 18805693)
1. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies.
Krungkrai J; Krungkrai SR; Supuran CT
Bioorg Med Chem Lett; 2008 Oct; 18(20):5466-71. PubMed ID: 18805693
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?
Krungkrai J; Scozzafava A; Reungprapavut S; Krungkrai SR; Rattanajak R; Kamchonwongpaisan S; Supuran CT
Bioorg Med Chem; 2005 Jan; 13(2):483-9. PubMed ID: 15598570
[TBL] [Abstract][Full Text] [Related]
3. Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential.
Krungkrai SR; Krungkrai J
Asian Pac J Trop Biomed; 2011 Jun; 1(3):233-42. PubMed ID: 23569766
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?
Innocenti A; Maresca A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Jul; 18(14):3938-41. PubMed ID: 18572406
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.
Poulsen SA; Wilkinson BL; Innocenti A; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2008 Aug; 18(16):4624-7. PubMed ID: 18644716
[TBL] [Abstract][Full Text] [Related]
6. Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.
Vullo D; Del Prete S; Fisher GM; Andrews KT; Poulsen SA; Capasso C; Supuran CT
Bioorg Med Chem; 2015 Feb; 23(3):526-31. PubMed ID: 25533402
[TBL] [Abstract][Full Text] [Related]
7. The alpha-carbonic anhydrase from the malaria parasite and its inhibition.
Krungkrai J; Supuran CT
Curr Pharm Des; 2008; 14(7):631-40. PubMed ID: 18336308
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
[TBL] [Abstract][Full Text] [Related]
12. Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data.
Fisher GM; Bua S; Del Prete S; Arnold MS; Capasso C; Supuran CT; Andrews KT; Poulsen SA
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):61-70. PubMed ID: 28129569
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy.
Reungprapavut S; Krungkrai SR; Krungkrai J
J Enzyme Inhib Med Chem; 2004 Jun; 19(3):249-56. PubMed ID: 15499996
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.
Carta F; Pothen B; Maresca A; Tiwari M; Singh V; Supuran CT
Chem Biol Drug Des; 2009 Aug; 74(2):196-202. PubMed ID: 19549076
[TBL] [Abstract][Full Text] [Related]
19. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
Tarko L; Supuran CT
Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
